Patents by Inventor Mark Ansermino

Mark Ansermino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11883631
    Abstract: A control system for administration of a drug comprises a drug administration actuator for administering the drug to a patient at a controllable dosage; a monitor for measuring an effect of the drug on the patient; and a controller configured to determine a control signal to the drug administration actuator; wherein the controller is configured to implement a closed loop model-predictive control scheme comprising, for each of a series of time steps, minimizing a cost function subject to one or more constraints to determine the control signal, the cost function based at least in part on a reference level and the monitor measurement; wherein the control signal is used as an input to an auxiliary model to estimate at least one concentration level of the drug in the patient; and wherein the constraints comprise at least one constraint on the estimate of the concentration level of the drug.
    Type: Grant
    Filed: February 1, 2022
    Date of Patent: January 30, 2024
    Assignee: The University of British Columbia
    Inventors: Guy Dumont, Mark Ansermino, Sara Khosravi, Nicholas West
  • Publication number: 20220211943
    Abstract: A control system for administration of a drug comprises a drug administration actuator for administering the drug to a patient at a controllable dosage; a monitor for measuring an effect of the drug on the patient; and a controller configured to determine a control signal to the drug administration actuator; wherein the controller is configured to implement a closed loop model-predictive control scheme comprising, for each of a series of time steps, minimizing a cost function subject to one or more constraints to determine the control signal, the cost function based at least in part on a reference level and the monitor measurement; wherein the control signal is used as an input to an auxiliary model to estimate at least one concentration level of the drug in the patient; and wherein the constraints comprise at least one constraint on the estimate of the concentration level of the drug.
    Type: Application
    Filed: February 1, 2022
    Publication date: July 7, 2022
    Applicant: The University of British Columbia
    Inventors: Guy Dumont, Mark Ansermino, Sara Khosravi, Nicholas West
  • Patent number: 11266780
    Abstract: A control system for administration of a drug comprises a drug administration actuator for administering the drug to a patient at a controllable dosage; a monitor for measuring an effect of the drug on the patient; and a controller configured to determine a control signal to the drug administration actuator; wherein the controller is configured to implement a closed loop model-predictive control scheme comprising, for each of a series of time steps, minimizing a cost function subject to one or more constraints to determine the control signal, the cost function based at least in part on a reference level and the monitor measurement; wherein the control signal is used as an input to an auxiliary model to estimate at least one concentration level of the drug in the patient; and wherein the constraints comprise at least one constraint on the estimate of the concentration level of the drug.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: March 8, 2022
    Assignee: University of British Columbia
    Inventors: Guy Dumont, Mark Ansermino, Sara Khosravi, Nicholas West
  • Publication number: 20220031945
    Abstract: The invention relates to administration of clinical anesthesia. Particular embodiments provide systems and methods for controlled delivery of a combination of an analgesic agent and a hypnotic agent. More specifically, the invention relates to closed-loop control systems/methods for automatically controlling the administration of a combination of a hypnotic agent and an analgesic agent in a clinical anesthesia setting which incorporate feedback based on one or more indirect measures/indicia of analgesia. The invention further relates to such control systems/methods that account for limitations of such indirect measures/indicia of analgesia.
    Type: Application
    Filed: August 10, 2021
    Publication date: February 3, 2022
    Applicant: The University of British Columbia
    Inventors: Guy Dumont, Klaske Van Heusden, Mark Ansermino
  • Patent number: 11116897
    Abstract: The invention relates to administration of clinical anesthesia. Particular embodiments provide systems and methods for controlled delivery of a combination of an analgesic agent and a hypnotic agent. More specifically, the invention relates to closed-loop control systems/methods for automatically controlling the administration of a combination of a hypnotic agent and an analgesic agent in a clinical anesthesia setting which incorporate feedback based on one or more indirect measures/indicia of analgesia. The invention further relates to such control systems/methods that account for limitations of such indirect measures/indicia of analgesia.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: September 14, 2021
    Assignee: The University of British Columbia
    Inventors: Guy Dumont, Klaske Van Heusden, Mark Ansermino
  • Publication number: 20190143036
    Abstract: The invention relates to administration of clinical anesthesia. Particular embodiments provide systems and methods for controlled delivery of a combination of an analgesic agent and a hypnotic agent. More specifically, the invention relates to closed-loop control systems/methods for automatically controlling the administration of a combination of a hypnotic agent and an analgesic agent in a clinical anesthesia setting which incorporate feedback based on one or more indirect measures/indicia of analgesia. The invention further relates to such control systems/methods that account for limitations of such indirect measures/indicia of analgesia.
    Type: Application
    Filed: April 12, 2017
    Publication date: May 16, 2019
    Applicant: The University of British Columbia
    Inventors: Guy Dumont, Klaske Van Heusden, Mark Ansermino
  • Patent number: 10219751
    Abstract: Methods, systems and related apparatus are provided to enable an electronic device to operate an external sensor comprising one or more emitters for emitting electromagnetic radiation of two different wavelengths and a detector for generating a response signal based on received electromagnetic radiation of the two different wavelengths connectable to an audio interface by applying a harmonic driving signal to a first contact and a second contact of the audio interface for driving the emitters of the external sensor, receiving the response signal at a third contact of the audio interface, demodulating and demultiplexing the response signal into a first wavelength response signal and a second wavelength response signal, analyzing the first and second wavelength response signals to determine one or more vital signs, and outputting the determined one or more vital signs.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: March 5, 2019
    Assignee: Lionsgate Technologies, Inc.
    Inventors: Christian Leth Petersen, John Mark Ansermino, Guy Dumont
  • Publication number: 20180296759
    Abstract: A control system for administration of a drug comprises a drug administration actuator for administering the drug to a patient at a controllable dosage; a monitor for measuring an effect of the drug on the patient; and a controller configured to determine a control signal to the drug administration actuator; wherein the controller is configured to implement a closed loop model-predictive control scheme comprising, for each of a series of time steps, minimizing a cost function subject to one or more constraints to determine the control signal, the cost function based at least in part on a reference level and the monitor measurement; wherein the control signal is used as an input to an auxiliary model to estimate at least one concentration level of the drug in the patient; and wherein the constraints comprise at least one constraint on the estimate of the concentration level of the drug.
    Type: Application
    Filed: November 23, 2016
    Publication date: October 18, 2018
    Applicant: The University of British Columbia
    Inventors: Guy Dumont, Mark Ansermino, Sara Khosravi, Nicholas West
  • Publication number: 20150133756
    Abstract: Methods, systems and related apparatus are provided to enable an electronic device to operate an external sensor comprising one or more emitters for emitting electromagnetic radiation of two different wavelengths and a detector for generating a response signal based on received electromagnetic radiation of the two different wavelengths connectable to an audio interface by applying a harmonic driving signal to a first contact and a second contact of the audio interface for driving the emitters of the external sensor, receiving the response signal at a third contact of the audio interface, demodulating and demultiplexing the response signal into a first wavelength response signal and a second wavelength response signal, analyzing the first and second wavelength response signals to determine one or more vital signs, and outputting the determined one or more vital signs.
    Type: Application
    Filed: January 21, 2015
    Publication date: May 14, 2015
    Inventors: Christian Leth PETERSEN, John Mark ANSERMINO, Guy DUMONT
  • Patent number: 8958859
    Abstract: Methods, systems and related apparatus are provided to enable an electronic device to operate an external sensor comprising one or more emitters for emitting electromagnetic radiation of two different wavelengths and a detector for generating a response signal based on received electromagnetic radiation of the two different wavelengths connectable to an audio interface by applying a harmonic driving signal to a first contact and a second contact of the audio interface for driving the emitters of the external sensor, receiving the response signal at a third contact of the audio interface, demodulating and demultiplexing the response signal into a first wavelength response signal and a second wavelength response signal, analyzing the first and second wavelength response signals to determine one or more vital signs, and outputting the determined one or more vital signs.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: February 17, 2015
    Assignee: Lionsgate Technologies, Inc.
    Inventors: Christian Leth Petersen, John Mark Ansermino, Guy Dumont
  • Publication number: 20140155708
    Abstract: Methods, systems and related apparatus are provided for controlling an electronic device to operate an external sensor connectable to an audio interface of the electronic device by applying a first harmonic driving signal to a first contact and a second harmonic driving signal to a second contact of the audio interface for driving the external sensor, receiving a response signal at a third contact of the audio interface, adjusting at least one of the first and second harmonic driving signals, determining one or more physiological parameters based on characteristics of the first and second harmonic driving signals and the response signal, and outputting the determined one or more physiological parameters.
    Type: Application
    Filed: May 13, 2013
    Publication date: June 5, 2014
    Applicant: LIONSGATE TECHNOLOGIES, INC.
    Inventors: Christian Leth Petersen, John Mark Ansermino, Guy Dumont
  • Publication number: 20140073887
    Abstract: Methods, systems and related apparatus are provided to enable an electronic device to operate an external sensor comprising one or more emitters for emitting electromagnetic radiation of two different wavelengths and a detector for generating a response signal based on received electromagnetic radiation of the two different wavelengths connectable to an audio interface by applying a harmonic driving signal to a first contact and a second contact of the audio interface for driving the emitters of the external sensor, receiving the response signal at a third contact of the audio interface, demodulating and demultiplexing the response signal into a first wavelength response signal and a second wavelength response signal, analyzing the first and second wavelength response signals to determine one or more vital signs, and outputting the determined one or more vital signs.
    Type: Application
    Filed: May 14, 2012
    Publication date: March 13, 2014
    Applicant: LONSGATE TECHNOLOGIES, INC.
    Inventors: Christian Leth Petersen, John Mark Ansermino, Guy Dumont